Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal cone cell | 4 studies | 17% ± 1% | |
| GABAergic neuron | 3 studies | 37% ± 10% | |
| glutamatergic neuron | 3 studies | 43% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 93% | 367.28 | 305 / 328 | 86% | 4.82 | 153 / 178 |
| brain | 93% | 1153.09 | 2446 / 2642 | 67% | 3.06 | 471 / 705 |
| stomach | 67% | 252.02 | 240 / 359 | 89% | 4.63 | 255 / 286 |
| intestine | 62% | 2248.04 | 598 / 966 | 93% | 5.93 | 492 / 527 |
| prostate | 43% | 125.18 | 105 / 245 | 96% | 5.14 | 483 / 502 |
| breast | 35% | 118.79 | 161 / 459 | 84% | 3.88 | 942 / 1118 |
| adrenal gland | 14% | 35.60 | 37 / 258 | 63% | 2.62 | 144 / 230 |
| bladder | 19% | 33.67 | 4 / 21 | 52% | 2.38 | 260 / 504 |
| thymus | 3% | 9.13 | 18 / 653 | 65% | 3.82 | 391 / 605 |
| esophagus | 14% | 32.72 | 200 / 1445 | 53% | 2.57 | 97 / 183 |
| lung | 5% | 10.09 | 27 / 578 | 58% | 3.06 | 666 / 1155 |
| lymph node | 0% | 0 | 0 / 0 | 41% | 0.81 | 12 / 29 |
| uterus | 2% | 6.74 | 4 / 170 | 38% | 1.44 | 173 / 459 |
| tonsil | 0% | 0 | 0 / 0 | 33% | 0.86 | 15 / 45 |
| ovary | 0% | 0 | 0 / 180 | 31% | 0.78 | 134 / 430 |
| kidney | 7% | 22.09 | 6 / 89 | 20% | 0.53 | 177 / 901 |
| liver | 0% | 0.73 | 1 / 226 | 21% | 1.08 | 85 / 406 |
| skin | 3% | 8.28 | 54 / 1809 | 2% | 0.04 | 10 / 472 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.05 | 1 / 80 |
| muscle | 0% | 0.61 | 2 / 803 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0.33 | 2 / 1204 | 0% | 0 | 0 / 0 |
| heart | 0% | 0.21 | 1 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0048013 | Biological process | ephrin receptor signaling pathway |
| GO_0006468 | Biological process | protein phosphorylation |
| GO_0008150 | Biological process | biological_process |
| GO_0007411 | Biological process | axon guidance |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0030425 | Cellular component | dendrite |
| GO_0005005 | Molecular function | transmembrane-ephrin receptor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | EPHA10 |
| Protein name | EPH receptor A10 EPHA10 protein Ephrin type-A receptor 10 (EC 2.7.10.1) |
| Synonyms | hCG_1820945 |
| Description | FUNCTION: Receptor for members of the ephrin-A family. Binds to EFNA3, EFNA4 and EFNA5. . |
| Accessions | Q5JZY3 ENST00000534097.5 ENST00000427468.6 ENST00000540011.2 H0YD12 ENST00000525749.1 ENST00000319637.6 [Q5JZY3-2] H0YER4 ENST00000432874.7 H0YEP6 F5GWI2 Q4G0R4 H0YCC9 ENST00000437645.5 ENST00000373048.9 [Q5JZY3-1] J3KQG3 |